tiprankstipranks

TPG GP A, LLC Insider Profile

81 Followers
TPG GP A, LLC, Former 10% Owner at Ceribell, Inc., holds 98.10M shares in Lifestance Health Group (Ticker: LFST), holds 3.77M shares in Ceribell, Inc. (Ticker: CBLL), holds 3.69M shares in Odyssey Therapeutics, Inc. (Ticker: ODTX). Most recently, TPG GP A, LLC Sold ― shares of Lifestance Health Group on Aug 12, 2026 for an estimated value of $144.89M.
tipranks
TPG GP A, LLC

TPG GP A, LLC
Ceribell, Inc. (CBLL)
Former 10% Owner

Ranked #767 out of 108,437 Corporate Insiders

Profitable Transactions

66%
29 out of 44 Profitable Transactions

Average Return

+31.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4B
26.46%
22.00%
14.87%
10.59%
26.08% Others
A breakdown of TPG GP A, LLC's holdings

Insider Roles

Lifestance Health Group
(LFST)
Ten Percent Owner
Life Time Group Holdings
(LTH)
Former 10% Owner
Nextpower Inc
(NXT)
Ten Percent Owner
ServiceTitan, Inc. Class A
(TTAN)
Former 10% Owner
+13 other positions
Roles that TPG GP A, LLC holds in companies

Most Profitable Insider Trade

Stock:
Sionna Therapeutics, Inc.
(SION)
Rating:Informative Buy
Date:Jul 01, 2025 - Jul 01, 2026
Return:+134.50%
The most profitable trade made by TPG GP A, LLC

TPG GP A, LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ceribell, Inc.
Jun 30, 2026
Former 10% Owner
Informative Sell
4.07M
$80.23M
ServiceTitan, Inc. Class A
Dec 17, 2024
Former 10% Owner
Uninformative Buy
$451.45M
Sionna Therapeutics, Inc.
Jan 26, 2026
Ten Percent Owner
Informative Sell
10.00M
$33.12M
Tpg Re Finance
Aug 07, 2025
Former 10% Owner
Uninformative Sell
$19.94M
BETA Technologies, Inc. Class A
Nov 07, 2025
Former 10% Owner
Uninformative Buy
$403.16M
Odyssey Therapeutics, Inc.
May 13, 2026
Former 10% Owner
Uninformative Buy
$75.09M
Trevi Therapeutics
Jul 06, 2022
Former 10% Owner
Informative Sell
1.44M
$68.08M
Cushman & Wakefield
May 24, 2024
Former 10% Owner
Informative Sell
188.08M
$0.00
Progyny
Aug 09, 2023
Former 10% Owner
Informative Sell
119.13M
$168.72M
Amneal Pharmaceuticals
Dec 14, 2022
Former 10% Owner
Informative Sell
9.09M
$210.82M
Nerdy
Nov 14, 2024
Former Director & 10% Owner
Uninformative Sell
$5.99M
TPG
Ten Percent Owner
Super League Enterprise
Aug 17, 2023
Former 10% Owner
Informative Sell
1.69M
$0.00
Nextpower Inc
Feb 07, 2024
Ten Percent Owner
Informative Sell
622.60M
$633.99M
Lifestance Health Group
Aug 12, 2026
Ten Percent Owner
Informative Sell
144.89M
$1.13B
Life Time Group Holdings
Jun 10, 2025
Former 10% Owner
Informative Sell
245.16M
$937.73M
Bicara Therapeutics Inc.
Sep 18, 2024
Former 10% Owner
Uninformative Buy
$46.58M
List of latest transactions for each holding click on a transaction to see TPG GP A, LLC's performance on stock

TPG GP A, LLC insider profile FAQ

What is the percentage of profitable transactions made by TPG GP A, LLC?
The percentage of profitable transactions made by TPG GP A, LLC is 66%.
    What is the average return per transaction made by TPG GP A, LLC?
    The average return per transaction made by TPG GP A, LLC is 31.70%.
      What stocks does TPG GP A, LLC hold?
      TPG GP A, LLC holds: CBLL, TTAN, SION, TRTX, BETA, ODTX, TRVI, CWK, PGNY, AMRX, NRDY, TPG, SLE, NXT, LFST, LTH, BCAX stocks.
        What was TPG GP A, LLC’s latest transaction?
        TPG GP A, LLC latest transaction was an Informative Sell of $144.89M.
          What was TPG GP A, LLC's most profitable transaction?
          TPG GP A, LLC’s most profitable transaction was an Informative Buy of SION stock on July 1, 2025. The return on the trade was 134.50%.
            What is TPG GP A, LLC's role in Ceribell, Inc.?
            TPG GP A, LLC's role in Ceribell, Inc. is Former 10% Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.